Learn how specialists at Liv Hospital diagnose glandular masses. Understand the advanced imaging tests, biopsies and clinical staging systems used for accurate evaluation.
Send us all your questions or requests, and our expert team will assist you.
Diagnosis and Staging
The diagnostic journey always begins with a deeply thorough clinical consultation and a highly detailed physical examination. When a patient arrives at Liv Hospital with suspicious physical symptoms our specialists conduct a meticulous review of their personal medical history and familial health background. This initial conversation provides crucial biological clues about the potential aggressiveness of the underlying issue.
Following the interview the physician determines which specific diagnostic tests and imaging technologies are strictly required to visualize the internal structures accurately and safely. The ultimate clinical goal is to definitively confirm the presence of abnormal cells precisely locate the primary mass and evaluate the surrounding lymphatic system for any signs of early microscopic spread.
Mammography is considered the absolute gold standard for visualizing soft glandular tissues within the chest cavity.
This highly advanced screening technology uses low dose X rays to create incredibly detailed cross sectional images of the internal structures.
During the procedure the tissue is gently compressed to spread the internal glands out evenly ensuring maximum visual clarity for the radiologist.
This specific compression allows the imaging machine to detect tiny calcium deposits or microscopic structural distortions long before a physical lump can actually be felt by a human hand.
Regular routine mammography is universally recognized as the single most effective clinical tool for reducing global mortality rates associated with this widespread disease.
While mammography is the primary diagnostic tool targeted ultrasound and magnetic resonance imaging are highly valuable in specific complex clinical scenarios.
A targeted ultrasound utilizes high frequency sound waves to create detailed composite images of the internal tissue structures completely without radiation.
It is particularly useful for quickly determining if a newly discovered lump is a harmless fluid filled cyst or a solid dense mass of tissue.
In some highly complex cases physicians may also utilize advanced magnetic resonance imaging.
In all clinical cases imaging alone cannot definitively determine the exact cellular makeup of the internal mass. A minimally invasive biopsy is a strict medical requirement to extract a tiny sample of the abnormal tissue for microscopic laboratory analysis. Using advanced ultrasound imaging for highly precise real time guidance the surgeon inserts a thin hollow needle directly into the core of the mass.
The safely extracted tissue samples are then sent immediately to a specialized pathologist for review. This highly precise outpatient procedure is performed comfortably under local anesthesia ensuring the mass is identified correctly without requiring a massive open surgical incision allowing the patient to return home the exact same day.
Modern pathology has advanced far beyond simply looking at cells through a standard microscope lens to determine their shape. Today specialists conduct deep molecular analysis and genetic testing for breast cancer on the extracted biopsy tissue to gather critical cellular data. They analyze the specific DNA of the patient to identify unique inherited genetic mutations that heavily drive the disease forward.
Identifying these specific inherited mutations can accurately predict how the mass will respond to specific pharmaceutical drugs and systemic therapies. This highly personalized cellular data allows the medical team to select the most precise and effective modern therapies available today, minimizing unnecessary side effects and maximizing clinical success.
Unlike other forms of benign illness, primary malignant masses are classified using a highly specific clinical staging system established by global health authorities. When patients ask what are the stages of breast cancer the oncology team carefully explains that staging evaluates the total size of the primary mass and how far the abnormal cells have traveled.
The official clinical stages range from zero to four indicating the escalating severity and anatomical spread of the biological disease. This comprehensive clinical evaluation is the absolute most critical factor in predicting how the mass will behave over time and heavily dictates the necessary therapeutic intensity required to achieve a total cure.
Understanding the distinct difference between the classifications helps patients properly grasp their specific medical prognosis. Early stage disease encompassing stages zero through two consist of localized cells that have not yet spread far beyond their original starting point. These specific localized growths often have clear distinct anatomical borders making them excellent candidates for complete surgical extraction.
Because the disease is caught incredibly early the long term survival rates are exceptionally high. The medical team focuses heavily on surgically removing the primary tumor entirely and utilizing localized therapies to ensure the immediate surrounding area remains completely clear of any hidden microscopic cellular threats.
When the disease progresses to stage three or four it is considered highly advanced and requires a much more complex systemic approach.
Managing advanced disease requires immense clinical expertise and access to the latest targeted medications to slow the progression and maintain the highest possible quality of life for the patient.
During the microscopic evaluation of the biopsy tissue the pathologist conducts vital receptor testing to understand what is biologically fueling the abnormal growth. They test the cells to see if they possess specific protein receptors for natural bodily hormones like estrogen and progesterone. If the cells test positive it means they are actively using the patient’s own hormones to multiply and thrive.
The pathologist also tests for the overproduction of a specific growth promoting protein. Understanding this precise molecular receptor status is absolutely critical because it opens the door for highly effective oral medications that specifically block these hormones starving the abnormal cells and preventing them from growing further.
Diagnosing and planning the treatment for these highly complex conditions requires the collaborative expertise of multiple medical disciplines working together seamlessly. At Liv Hospital every single patient case is presented to a specialized multidisciplinary tumor board for a comprehensive collaborative review. This collaborative team includes expert surgical oncologists, radiation specialists, radiologists and pathologists.
By reviewing the imaging scans, biopsy results and genetic profiles together the board members share their unique clinical perspectives to formulate a perfectly optimized world class treatment plan. This rigorous collaborative review process guarantees that every possible therapeutic angle is deeply considered ensuring maximum patient safety.
Liv Hospital Ulus
Assoc. Prof. MD. Evrim Duman
Radiation Oncology
Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam
Medical Oncology
Liv Hospital Ulus
Prof. MD. Duygu Derin
Medical Oncology
Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda
Radiation Oncology
Liv Hospital Ulus
Prof. MD. Meral Günaldı
Medical Oncology
Liv Hospital Vadistanbul
Assoc. Prof. MD. Murat Ayhan
Medical Oncology
Liv Hospital Vadistanbul
Prof. MD. Itır Şirinoğlu Demiriz
Hematology
Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan
Pediatric Hematology and Oncology
Liv Hospital Bahçeşehir
Assoc. Prof. MD. Erkan Kayıkçıoğlu
Medical Oncology
Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez
Gynecological Oncology
Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan
Medical Oncology
Liv Hospital Bahçeşehir
MD. Taylan Bükülmez
Radiation Oncology
Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter
Gynecological Oncology
Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan
Medical Oncology
Liv Hospital Bahçeşehir
Prof. MD. Yasemin Altuner Torun
Pediatric Hematology and Oncology
Liv Hospital Bahçeşehir
Spec. MD. Vildan Kayku
Medical Oncology
Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan
Medical Oncology
Liv Hospital Topkapı
Assoc. Prof. MD. Emir Çelik
Medical Oncology
Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı
Medical Oncology
Liv Hospital Topkapı
Prof. MD. İrfan Çiçin
Medical Oncology
Liv Hospital Ankara
Assoc. Prof. MD. Ramazan Öcal
Hematology
Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan
Gynecological Oncology
Liv Hospital Ankara
Prof. MD. Fikret Arpacı
Medical Oncology
Liv Hospital Ankara
Prof. MD. Gökhan Erdem
Medical Oncology
Liv Hospital Ankara
Prof. MD. Meral Beksaç
Hematology
Liv Hospital Ankara
Prof. MD. Oral Nevruz
Hematology
Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap
Medical Oncology
Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu
Medical Oncology
Liv Hospital Ankara
Spec. MD. Ender Kalacı
Medical Oncology
Liv Hospital Gaziantep
Assoc. Prof. MD. Fadime Ersoy Dursun
Hematology
Liv Hospital Gaziantep
Prof. MD. Fatih Teker
Medical Oncology
Liv Bona Dea Hospital Bakü
Spec. MD. ELXAN MEMMEDOV
Medical Oncology
Spec. MD. Ceyda Aslan
Hematology
Spec. MD. Elkhan Mammadov
Medical Oncology
Spec. MD. Elmir İsrafilov
Hematology
Spec. MD. Minure Abışova Eliyeva
Hematology
Spec. MD. Natavan Azizova
Medical Oncology
Liv Hospital Ulus + Liv Hospital Bahçeşehir
Prof. MD. Mehmet Hilmi Doğu
Hematology
Send us all your questions or requests, and our expert team will assist you.
Most core needle biopsies are performed smoothly using only local numbing anesthesia so the patient remains completely awake, comfortable and feels no sharp pain.
The medical team will always meticulously check your kidney function through a simple blood test before administering any contrast dye to ensure absolute physical safety.
Standard microscopic results may take a few days while highly comprehensive molecular and genetic receptor testing can take up to two full weeks to process.
If you suffer from severe claustrophobia the medical team can provide mild relaxing medications to help you remain perfectly calm and still during the scanning process.
Yes it is entirely possible for an untreated localized mass to grow larger over several months and eventually transition into a more aggressive advanced stage.
BlogBreast CancerJun 04, 2026Learn about skin sparing mastectomy, a proven technique that preserves skin to improve breast reconstructio...
BlogBreast CancerMay 04, 2026Explore the history, significance, and ongoing efforts behind breast cancer awareness, a vital health obser...
BlogBreast CancerMay 04, 2026Understand the key breast malignancy types, from hormone receptor-positive to HER2-positive. Find comprehen...
BlogBreast CancerApr 24, 2026Discover the 7 early signs of male breast tumor symptoms, including a firm, painless lump and nipple change...
BlogBreast CancerApr 24, 2026Discover the 7 early signs of a brain tumor, especially for women. Learn how to recognize symptoms and get ...
BlogBreast CancerApr 24, 2026Experiencing a burning feeling in your breast? Our guide covers the top causes, including hormonal fluctuat...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 174 28 17